• 基本信息
    导师姓名: 黄雷 学科代码: 100100
    性别: 学科名称: 基础医学
    培养单位: 基础医学院 三级学科
    导师类型: 博士生导师 专业领域名称:
    联系方式: 上海交通大学医学院组织胚胎学与遗传发育系 上海市重庆南路280号5号楼505 室 200025 电话:021-63846590-776576 专业领域代码:
    邮编: 200025 邮箱地址: leihuang@shsmu.edu.cn
  • 研究方向 (点击浏览详细信息)
  • 社会任职
     
    上海病理生理学会理事
    黄浦区人大代表
    上海交通大学医学院“中青年知识分子联谊会”副会长
    美国人类遗传学会会员、中国遗传学会会员、中国细胞生物学学会会员
  • 科研项目
    项目编号项目名称课题来源起止年月批准经费承担职责
    82073111黏蛋白1泛素化修饰的动态调控机制及其肿瘤治疗意义研究国家自然科学基金面上项目 2021-01~2024-12 55万元  课题负责人
    81874197黏蛋白1调控肿瘤干细胞分裂模式的机制及临床意义研究国家自然科学基金面上项目 2019-01~2022-12 57万元  课题负责人
    2015CB910403代谢应激过程中蛋白质修饰相关的生物标志物和潜在靶点的发现国家重大研究计划项目 2015-01~2019-12 60万元  课题参与人
    81472461MUC1在产后乳腺退化中的作用及其与TNBC发病的关系研究 国家自然科学基金面上项目 2015-01~2018-12 72万元  课题负责人
    81272262MUC1在肺癌早期发生和转移中的作用和机制研究 国家自然科学基金面上项目 2013-01~2016-12 80万元  课题负责人
    2012CB967000肿瘤干细胞的动态演进及干预研究国家重大研究计划项目 2012-01~2016-12 92万元  课题参与人
    11140902600乳腺癌小鼠模型的建立及肿瘤发生机制研究上海市科委实验动物研究项目 2011-12~2013-09 20万元  课题负责人
    81071666MDMX基因定点诱变小鼠模型的建立及其生物学功能研究国家自然科学基金面上项目 2011-01~2013-12 35万元  课题负责人
    NCET-08-0349MUC1在肺癌治疗中的作用及其机制研究教育部“新世纪优秀人才支持计划 2009-01~2011-12 50万元  课题负责人
    30871363MUC1在乳腺癌治疗中的作用及其机制研究国家自然科学基金面上项目 2009-01~2011-12 35万元  课题负责人
    07pj14065MUC1在肺癌发病和治疗中的作用及其机制研究上海市科委“浦江人才计划” 2007-09~2009-09 20万元  课题负责人
    30671169MUC1过度表达小鼠模型的建立及其致瘤机制研究国家自然科学基金面上项目 2007-01~2009-12 30万元  课题负责人
  • 学术论文
    作者论文标题期刊名出版年卷期页码
    Morimoto Y, Fushimi A, Yamashita N, Hagiwara M, Bhattacharya A, Cheng J, Frost TC, Ahmad R, Daimon T,, Hata T, Takahashi H, Yamamoto M, Suzuki Y, DeCaprio JA, Kufe D*.  Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment  Oncogene  2022  41(27):3511-3523 
    Li Q, Chu Y, Li S, Yu L, Deng H, Liao C, Liao X, Yang C, Qi M, Cheng J, Chen G,  The oncoprotein MUC1 facilitates breast cancer progression by promoting Pink1-dependent mitophagy via ATAD3A destabilization.  Cell Death & Disease.  2022  13(10): 899-915 
    Pang Z#,Dong X#,Deng H#,Wang C,Liao X,Liao C,Liao Y,Tian W,Cheng Jinke,Chen G,Yi H*,  MUC1 triggers lineage plasticity of Her2 positive mammary tumors  Oncogene  2022  41(22):3064-3078 
    Liao C, Yu L, Pang Z, Deng H, Liao X, Li S, Cheng J, Qi M*, Chen G*,  WWP1 targeting MUC1 for ubiquitin-mediated lysosomal degradation to suppress carcinogenesis  Signal Transduction and Targeted Therapy  2021  6(1):297-300 
    Guan Y,Wang Y,Li B,Shen K,Li Q,Ni Y*,  Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics.  Cancer Cell International.  2021  21(350):1-9 
    Wu AY, Gu LY, Cang W, Cheng MX, Wang WJ, Di W,, Qiu LH*.   Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation.  J Exp Clin Cancer Res.   2019  38 (1):176. 
    Lv Y, Cang W, Li Q, Liao X, Zhan M, Deng H, Li S, Jin W, Pang Z, Qiu X, Zhao K, Chen G, Qiu L*,  Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer  Oncogenesis  2019  8(12):70 
    Wang Y, Liao X, Ye Q*,  Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma.  Sci China Life Sci.  2018  61(11):1389-1395. 
    Gamze Kuser-Abali, Lu Gong, Jiawei Yan, Qingqing Liu, Weiqi Zeng, Amanda Williamson, Chuan Bian Lim, Mary Ellen Molloy, John B. Little,, Zhi-Min Yuan.  An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage.   Proc Natl Acad Sci U S A.  2018  115(13):3452-3457. 
    Yuan Li, Zhi Pang, Xinran Dong, Xiaodong Liao, Huayun Deng, Chunhua Liao, Yahui Liao, Guoqiang Chen,  MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer.  Oncotarget.  2018  9 (3): 3446-3458  
    Hu Y, Li D, Wu A, Qiu X, Di W,, Qiu L*.  TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA.  Cancer Lett.   2017  393:60-67. 
    Fu RJ, He W, Wang XB, Li L, Zhao HB, Liu XY, Pang Z, Chen GQ,, Zhao KW*.  DNMT1-mediated hypermethylation of Krüppel-like factor 5 regulates the progression of clear cell renal cell carcinoma.  Cell Death & Disease  2017  8(7):e2952. 
    Jin W, Liao X, Lv Y, Pang Z, Wang Y, Li Q, Liao Y, Ye Q, Chen G, Zhao K*,  MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner.  Cell Death & Disease  2017  8(8):e2980 
    Zhao XY, Li L, Wang XB, Fu RJ, Lv YP, Jin W, Meng C, Chen GQ,, Zhao KW*.  Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells.  PLoS ONE.  2016  11(10):e0164752. 
    Wang Y, Shang W, Lei X, Shen S, Zhang H, Wang Z,, Yu Z, Ong H, Yin X, Yang W, Zhang C.   Opposing functions of PLAG1 in pleomorphic adenoma: a microarray analysis of PLAG1 transgenic mice   Biotechnol Lett  2013  35(9):1377-85 
    Wang F, Wang PX, Wu XL, Dang SY, Chen Y, Ni YY, Gao LH, Lu SY, Kuang Y,, Fei J, Wang ZG, Pang XF.  Deficiency of Adiponectin Protects against Ovariectomy-Induced Osteoporosis in Mice.  PLoS One  2013  8(7):e68497. 
    Xu WY, Gu MM, Sun LH, Guo WT, Zhu HB, Ma JF, Yuan WT, Kuang Y, Ji BJ, Wu XL, Chen Y, Zhang HX, Sun FT, Huang W,, Chen SD, Wang ZG.  A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in a large Chinese pedigree.  Am J Hum Genet  2012  91(6):1088-94. 
    Li Y, Yi H, Yao Y, Liao X, Xie Y, Yang J, Yan Z, Wang L, Lu S, Kuang Y, Gu M, Fei J, Wang Z,  The Cytoplasmic Domain of MUC1 Induces Hyperplasia in the Mammary Gland and Correlates with Nuclear Accumulation of β-catenin.   PLoS ONE  2011  6(4):e19102 
    Shen S, Yang W, Wang Z, Lei X, Xu L, Wang Y, Wang L,, Yu Z, Zhang X Li J, Chen Y, Zhao X, Yin X, Zhang C.  . Tumor-Initiating Cells Are Enriched in CD44(hi) Population in Murine Salivary Gland Tumor.   PLoS ONE.  2011  6(8) 
    Ye Q, Yan Z, Liao X, Li Y, Yang J, Sun J, Kawano T, Wang X, Cao Z,Wang Z,  MUC1 induces metastasis in esophageal squamous cell carcinoma by upregulating matrix metalloproteinase 13  Lab Invest  2011  91(5):778-87 
    , Yan Z, Liao X, Li Y, Yang J, Wang ZG, Zuo Y, Kawai H, Shadfan M, Ganapathy S, Yuan ZM.  The MDM2/MDMX complex is required for control of p53 activity in vivo.  Proc Natl Acad Sci U S A.  2011  108(29):12001-6 
    Shen S, Yang W, Wang Z, Lei X, Xu L, Wang Y, Wang L,, Yu Z, Zhang X Li J, Chen Y, Zhao X, Yin X, Zhang C.  . Tumor-Initiating Cells Are Enriched in CD44(hi) Population in Murine Salivary Gland Tumor.   PLoS ONE.  2011  6(8) 
    , Liao X., Beckett M., Li Y., Khanna K. K., Wang Z., Kharbanda S., Weichselbaum R. and Kufe D.  MUC1 Oncoprotein Interacts Directly With ATM and Promotes the DNA Damage Response to Ionizing Radiation.  Genes & Cancer.  2010  1(3):239-250 
    Macdermed DM, Khodarev NN, Pitroda SP, Edwards DC, Pelizzari CA,, Kufe DW, Weichselbaum RR.  MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients.  BMC Med Genomics.   2010  3(1):16.1-12 
    Khodarev NN, Pitroda SP, Beckett MA, Macdermed DM,, Kufe DW, Weichselbaum RR.  MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung.   Cancer Res.  2009  69(7):2833-7 
    Wu XL, Gu MM,, Liu XS, Zhang HX, Ding XY, Xu JQ, Cui B, Wang L, Lu SY, Chen XY, Zhang HG, Huang W, Yuan WT, Yang JM, Gu Q, Fei J, Chen Z, Yuan ZM, Wang ZG.  Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene.  Am J Hum Genet.  2009  85(1):53-63. 
    Leng Y, Cao C, Ren J,, Chen D, Kufe D.  Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62.   J Biol Chem.  2007  282(27):19321-30 
    Ren J, Raina D, Chen W, Li G,, Kufe D.   MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling.   Mol Cancer Res.  2006  4(11):873-83. 
    , Chen D., Liu D, Yin L, Kharbanda S, Kufe D.   MUC1 Oncoprotein Blocks Glycogen Synthasa Kinase 3β-Mediated Phosphorylation and Degradation of β-catenin.  Cancer Research.  2005  65(22) :10413-10422 
    Ren J, Agata N, Chen D, Li Y, Yu WH,, Raina D, Chen W, Kharbanda S, Kufe D.   Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents.   Cancer Cell.  2004  5(2):163-75. 
    Yin L,, Kufe D.   MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress.  J Biol Chem.  2004  279(44):45721-7 
    , Ren J, Chen D, Li Y, Kharbanda S, Kufe D.   MUC1 Cytoplasmic Domain Coactivates Wnt Target Gene Transcription and Confers Transformation.  Cancer Biol Ther.  2003  2(6):702-706.